// App-Quantinova.ai

TCT-802 : Impact of diabetes mellitus on 1-year outcomes of Absorb Bioresorbable vascular scaffold vs. Everolimus-eluting Metallic stent: a propensity matched Analysis of COMPARE II, RAI and MAASSTAD-ABSORB Prospective Registries

Researchers

Presenter

  • Giuseppe Tarantini

Principal Investigators

  • Marco Mojoli

  • Giulia Masiero

  • Bernardo Cortese

  • Gaetano Di Palma

  • Giuseppe Steffenino

  • Attilio Varricchio

  • Alfonso Ielasi

  • Bruno Loi

  • Daisuke Ueshima

  • Paola Tellaroli

  • Valeria Paradies

  • Georgios Vlachojannis

  • Pieter Smits

Medical Centers

  • Ospedale Bolognini, Seriate, Bergamo, Italy

  • Tokyo Medical and Dental University, Tokyo, Japan

  • Cardiology Division, Santa Maria della Pietà Hospital, Nola, NA, Italy, Naples, Naples, Italy

  • Interventional Cardiology Unit, Azienda Ospedaliera Brotzu, Cagliari, Cagliari, Italy

  • University of Padua - Department of Cardiac, Thoracic and Vascular Sciences, Padova, Padua, Italy

  • US Emodinamica, A.S.O.S. Croce e Carle, Cuneo, Cuneo, Italy

  • Maasstad Hosp, Rotterdam, Netherlands

  • Biostatistics, Epidemiology and Public Health Unit of Department of Cardiac, Thoracic and Vascular Sciences, University of Padua Medical School, Padua, Italy, Padua, Padua, Italy

  • Unità Operativa di Cardiologia, ASST Fatebenefratelli-Sacco, P.O. Fatebenefratelli, Milan, Milan, Italy

  • National Heart Research Institute and National Heart Centre Singapore, Singapore, Singapore

Locations

  • Italy

  • Netherlands

  • Japan

  • Singapore

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Endocrine/metabolic Diseases (ME)

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Diabetes

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved